Pfenex Company
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.
%20.jpg)
%20.jpg)
Funding Status:
M&A
Headquarters:
San Diego, California, United States
Founded Date:
2009
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Industry:
PharmTech
Technology:
Cancer
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A